Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
This consultation sought your views on a number of proposals to improve the operation of the medicines’ supply chain in the UK. It also sought views on European Commission proposals to amend Directive 2001/83/EC with the aim of reducing the risk of counterfeit medicines entering the legitimate supply chain in Europe.
The deadline for comments was 13 March 2009.
The outcome of this consultation and a list of responses are available below as download documents.
-
Vetoquinol UK Ltd
(13Kb)
-
G D Cooper & Co Ltd
(19Kb)
-
Unknown
(13Kb)
-
Benoliel Partners
(1007Kb)
-
Charles McEvoy
(13Kb)
-
Dace Kikute
(13Kb)
-
Philip Ward
(13Kb)
-
SD Healthcare
(13Kb)
-
GDP Consultant
(310Kb)
-
Carters Chemist
(9Kb)
-
BBC Pharmaservices
(8Kb)
-
Pharmacy Consulting Ltd
(146Kb)
-
SFG Solutions Ltd
(131Kb)
-
Frank Bagshaw Ltd
(60Kb)
-
Unknown
(8Kb)
-
Blue Chip Healthcare Ltd
(19Kb)
-
NHS Somerset
(9Kb)
-
Confidential response
-
Partially Confidential
(9Kb)
-
Polarspeed Distribution
(58Kb)
-
W Davidson and Sons Ltd
(80Kb)
-
Bio Products Laboratory
(45Kb)
-
Orion Pharma
(122Kb)
-
Unknown
(13Kb)
-
UniDrug Distribution Group Ltd
(171Kb)
-
M&GS IPT (MOD) (No comments)
-
Pharmarama Int'l Ltd
(27Kb)
-
Sylvan Manuscripts
(15Kb)
-
Unknown
(13Kb)
-
Aegate Ltd
(67Kb)
-
Integrated Marketing Contact Ltd
(460Kb)
-
Royal Society of Chemistry
(14Kb)
-
Dr Jonathan Sheard
(142Kb)
-
Moorfields NHS
(19Kb)
-
Coventry PCT
(14Kb)
-
National Services Scotland
(111Kb)
-
Nordic Pharma UK Ltd
(95Kb)
-
Idis
(57Kb)
-
Fresenius Kabi Oncology Plc
(14Kb)
-
Guys and St Thomas' NHS Trust
(226Kb)
-
Confidential response
-
Rxchange Ltd
(201Kb)
-
Johnson & Johnson
(42Kb)
-
Asked for name to be withheld
(582Kb)
-
NHS Borders
(13Kb)
-
Baxter Healthcare Ltd
(70Kb)
-
General Optical Council
(13Kb)
-
Confidential response
-
GE Healthcare Ltd
(49Kb)
-
Takeda
(3275Kb)
-
HTF Associates Ltd
(103Kb)
-
Allergan
(366Kb)
-
The Priestly Centre
(18Kb)
-
AAH Pharmaceuticals Ltd
(481Kb)
-
Norgine Ltd
(432Kb)
-
Yorkhill Pharmacy
(21Kb)
-
Glaxo Smith Kline
(67Kb)
-
Roche Products Ltd
(34Kb)
-
Pfizer Ltd
(95Kb)
-
GS1 UK
(32Kb)
-
Lilly Europe
(85Kb)
-
Boots UK
(233Kb)
-
Vygon (UK) Ltd
(16Kb)
-
University College Dublin
(16Kb)
-
Novonordisk
(14Kb)
-
South East Coast SHA
(164Kb)
Download documents:
-
1. Public consultation (MLX 357): Consultation on measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines (271Kb)
-
2. Impact Assessment of the European Commission’s proposal to tackle the threat of counterfeiting (1327Kb)
-
3. Public consultation (MLX 357): Consultation list - Annex C (85Kb)
-
4. MLX 357 - Outcome (44Kb)
-
5. MLX 357 - List of responses (84Kb)

